Sickle cell disease (SCD) is a chronic genetic disease that requires lifelong therapy and monitoring. Low drug adherence and poor monitoring may lead to an increase in morbidities and low quality of life. In the era of digital technology, various mobile health (mHealth) apps are being tested for their potential in increasing drug adherence in patients with SCD. We herewith discuss the applicability and feasibility of these mHealth apps for the management of SCD in India.
CITATION STYLE
Kumar, R., & Das, A. (2021, April 1). The potential of mHealth as a game changer for the management of sickle cell disease in India. JMIR MHealth and UHealth. JMIR Publications Inc. https://doi.org/10.2196/25496
Mendeley helps you to discover research relevant for your work.